Page last updated: 2024-12-07

isofloxythepin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Isofloxythepin is a tricyclic antidepressant (TCA) with a unique chemical structure. It was synthesized in the 1960s and initially studied as a potential antipsychotic. While its antipsychotic activity was limited, research revealed antidepressant effects and a distinct mechanism of action compared to other TCAs. Isofloxythepin primarily acts as a serotonin antagonist and a weak dopamine antagonist, offering a potential therapeutic advantage in treating depression with minimal side effects associated with other TCAs. Recent research has explored its potential in treating anxiety disorders and neuropathic pain. The unique pharmacological profile and potential therapeutic applications make isofloxythepin an interesting subject for ongoing research.'

isofloxythepin: RN given refers to unlabeled cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID115193
CHEMBL ID4573312
SCHEMBL ID1649426
MeSH IDM0077756

Synonyms (24)

Synonym
isofloxythepin
1-piperazineethanol, 4-(10,11-dihydro-3-fluoro-8-(1-methylethyl)dibenzo(b,f)thiepin-10-yl)-
7-fluoro-11-(4-(2-hydroxyethyl)piperazino)-2-isopropyl-10,11-dihydrodibenzo(b,f)thiepin
4-(3-fluoro-10,11-dihydro-8-isopropyldibenzo(b,f)thiepin-10-yl)piperazine-1-ethanol
einecs 275-028-1
1-piperazineethanol, 4-(3-fluoro-10,11-dihydro-8-(1-methylethyl)dibenzo(b,f)thiepin-10-yl)-
AKOS005065677
unii-4p96gsf1nj
4p96gsf1nj ,
70931-18-9
1-piperazineethanol, 4-(3-fluoro-10,11-dihydro-8-(1- methylethyl)dibenzo(b,f)thiepin-10-yl)-
1-piperazineethanol, 4-(10,11-dihydro-3-fluoro-8-(1- methylethyl)dibenzo(b,f)thiepin-10-yl)-
7-fluoro-11-(4-(2-hydroxyethyl)piperazino)-2-isopropyl- 10,11-dihydrodibenzo(b,f)thiepin
4-(3-fluoro-10,11-dihydro-8-isopropyldibenzo(b,f)thiepin-10- yl)piperazine-1-ethanol
SCHEMBL1649426
3-fluoro-10-[4-(2-hydroxyethyl)piperazino]-8-isopropyl-10,11-dihydrodibenzo (b,f) thiepin
XDBMBHVYXPBOPL-UHFFFAOYSA-N
4-[3-fluoro-10,11-dihydro-8-isopropyldibenzo[b,f]thiepin-10-yl]piperazine-1-ethanol
2-{4-[3-fluoro-8-(propan-2-yl)-10,11-dihydrodibenzo[b,f]thiepin-10-yl]piperazin-1-yl}ethan-1-ol
DTXSID90991216
Q27260323
2-(4-(3-fluoro-8-isopropyl-10,11-dihydrodibenzo[b,f]thiepin-10-yl)piperazin-1-yl)ethan-1-ol
CHEMBL4573312
bdbm442750

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (25)

TimeframeStudies, This Drug (%)All Drugs %
pre-199023 (92.00)18.7374
1990's2 (8.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials4 (15.38%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other22 (84.62%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]